Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Goldman Sachs Group Inc reported a 5.10% stake in Karyopharm Therapeutics Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
Goldman Sachs Group Inc reported a 5.10% stake in Karyopharm Therapeutics Inc., 991,364 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 991,364
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 5.10% | 991,364 |
| GOLDMAN SACHS & CO. LLC | 5.10% | 991,364 |
Source
Related
- Karyopharm Therapeutics Inc.
- Goldman Sachs Group Inc
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 11, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026